Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Abilify as Adjunctive Treatment for Major Depressive Disorder
NCT01696617Phase 4Completed
- Sponsor
- Seoul National University Hospital
- Start
- Feb 2012
- Primary completion
- Dec 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of aripiprazole in major depressive disorder (MDD), sponsored by Seoul National University Hospital. Started Feb 2012; status: completed.
02
Drugs
aripiprazole
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT01696617.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01696617.